Search For "drug controller"
CSIR to begin two clinical drug trials to combat COVID-19
Updated : 5 years, 10 months ago IST
New Delhi [India], May 8 (ANI): The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - 'favipiravir' and 'phytopharmaceutical' - to combat coronavirus.
Read More
Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical t
Updated : 5 years, 10 months ago IST
New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila, the leading global pharmaceutical company in India, to conduct clinical trial using antiviral drug 'Pegylated Interferon Alpha-2b' in adul
Read More
COVID-19: AIIMS Bhopal conducting multicentric study on Mycobacterium w
Updated : 5 years, 10 months ago IST
Bhopal (Madhya Pradesh) [India], April 30 (ANI): A multicentric study on the use Mycobacterium w (Mw), heat-killed Mycobacterium indicus pranii, as an adjunct to the treatment of coronavirus is being conducted at AIIMS Bhopal with the approval of Drug Controller General of India.
Read More
Glenmark to conduct clinical trials on Favipiravir anti-viral tablets for
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], April 30 (ANI): Glenmark Pharmaceuticals said on Thursday it has received approval from the Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir anti-viral tablets on COVID-19 patients.
Read More
DCGI permits import of drug with residual shelf life less than 60 pc
Updated : 5 years, 11 months ago IST
New Delhi [India], April 18 (ANI): In view of the COVID-19 pandemic, the country's top drug controller has granted permission for the import of drugs with residual shelf life less than 60 per cent under special conditions. This will be effective for a period of three months or till further o
Read More
Small scale pharmas in Haridwar stop manufacturing hydroxychloroquine as p
Updated : 5 years, 11 months ago IST
Dehradun (Uttarakhand) [India], April 14 (ANI): While the demand for hydroxychloroquine tablets keeps on rising worldwide, small pharmaceutical manufacturers in Haridwar have stopped producing the drug due to the sharp increase in the cost of raw materials, according to Anil Sharma, Presiden
Read More
Efforts being made to speed up production of hydroxychloroquine in Himacha
Updated : 5 years, 11 months ago IST
Baddi (Himachal Pradesh) [India], April 11 (ANI): With the demand for hydroxychloroquine, an anti-malarial drug, rising substantially in the wake of coronavirus pandemic, efforts are being made to speed up its production in Himachal Pradesh.
Read More
NPPA unit to monitor drug pricing set up in J-K
Updated : 5 years, 11 months ago IST
Srinagar (Jammu and Kashmir) [India], April 1 (ANI): The National Pharmaceutical Pricing Authority (NPPA) has set up a Price Monitoring and Resource Unit (PMRU) in Jammu and Kashmir. Till now, 11 states including Kerala, Odisha, Gujarat, Rajasthan, Punjab, Haryana, Nagaland, Tripura, Uttar P
Read More
DGCI gives test license to 18 companies to conduct COVID-19 tests
Updated : 5 years, 12 months ago IST
New Delhi [India], Mar 20 (ANI): The Drug Controller General of India (DCGI) has given test licence to 18 companies including international and private companies to conduct coronavirus (COVID-19) tests in India.
Read More
Fake hand sanitizer manufacturing company busted in Gurugram, 5K bottles s
Updated : 6 years ago IST
Gurugram (Haryana) [India], Mar 12 (ANI): Haryana Food and Drug Administration on Thursday busted a fake hand sanitizer manufacturing company and seized at least 5,000 hand sanitizers, said drug controller officer, Ripan Mehta.
Read More
Zydus announces world's first drug for treatment of NASH
Updated : 6 years ago IST
Ahmedabad (Gujarat) [India], Mar 5 (ANI): Global pharmaceutical company Zydus Cadila, on Thursday announced that the Drug Controller General of India (DCGI) has approved its new drug application (NDA) for Saroglitazar, a medicine for the treatment of a liver disease called Non-Cirrhotic Non-
Read More
Punjab Health Minister hands over appointment letters to 11 drugs controll
Updated : 6 years, 2 months ago IST
Chandigarh (Punjab) [India], Jan 1 (ANI): To further improve the functioning of Punjab's Food and Drug Administration Department (FDA), Health Minster Balbir Singh Sidhu on Wednesday handed over the appointment letters to 11 drugs controller officers.
Read More